(Q38051893)

27 August 2017

title

Tools from viruses: bacteriophage successes and beyond (English)

1 reference

27 August 2017

1 reference

2

Laurent Debarbieux

1 reference

27 August 2017

Marine Henry

1

1 reference

27 August 2017

language of work or name

English

0 references

publication date

12 October 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

434

1 reference

27 August 2017

issue

2

1 reference

27 August 2017

page(s)

151-161

1 reference

Random sequence libraries displayed on phage: identification of biologically important molecules.

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Characterization of phage that bind plastic from phage-displayed random peptide libraries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Biological targeting and innovative therapeutic interventions with phage-displayed peptides and structured nucleic acids (aptamers).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Biocontrol of Listeria monocytogenes and Escherichia coli O157:H7 in meat by using phages immobilized on modified cellulose membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Viral nanoparticles donning a paramagnetic coat: conjugation of MRI contrast agents to the MS2 capsid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Steps toward mapping the human vasculature by phage display.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Virus-polymer hybrid nanowires tailored to detect prostate-specific membrane antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Defining criteria for oligomannose immunogens for HIV using icosahedral virus capsid scaffolds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Multivalent display and receptor-mediated endocytosis of transferrin on virus-like particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Lambda-display: a powerful tool for antigen discovery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Engineered phage-based therapeutic materials inhibit Chlamydia trachomatis intracellular infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Rapid detection methods for viable Mycobacterium avium subspecies paratuberculosis in milk and cheese.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Progress in phage display: evolution of the technique and its application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Metal-recognition by repeating polypeptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Pseudomonas biofilms, cystic fibrosis, and phage: a silver lining?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Phage-displayed antibody fragments recognizing dengue 3 and dengue 4 viruses as tools for viral serotyping in sera from infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Phage display of combinatorial peptide libraries: application to antiviral research.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Cowpea mosaic virus: from the presentation of antigenic peptides to the display of active biomaterials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Chemical conjugation of heterologous proteins on the surface of Cowpea mosaic virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

A rapid method for efficient gene replacement in the filamentous fungus Aspergillus nidulans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Therapeutic applications of the ΦC31 integrase system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Targeted binding of the M13 bacteriophage to thiamethoxam organic crystals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Bacteriophage-based biocontrol of biological sludge bulking in wastewater

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Genetically engineered liquid-crystalline viral films for directing neural cell growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Phage and their lysins as biocontrol agents for food safety applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Assessment of Escherichia coli O157:H7-specific bacteriophages e11/2 and e4/1c in model broth and hide environments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Diversity of phage-displayed libraries of peptides during panning and amplification.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Bacteriophage-mediated protein delivery into the central nervous system and its application in immunopharmacotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Preventing biofilms of clinically relevant organisms using bacteriophage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Assembly of functional bacteriophage lambda virions incorporating C-terminal peptide or protein fusions with the major tail protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

High-sensitivity bacterial detection using biotin-tagged phage and quantum-dot nanocomplexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Recombinant bacteriophage lysins as antibacterials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Bacteriophage lysins as effective antibacterials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Biocontrol of Ralstonia solanacearum by treatment with lytic bacteriophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Peptide-displaying phage technology in glycobiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Bacteriophages and their application in food safety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Glycobiomimics and glycobiosensors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Chemical modification of a viral cage for multivalent presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Phage-based biocontrol strategies to reduce foodborne pathogens in foods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Biocontrol of Salmonella Typhimurium in RTE foods with the virulent bacteriophage FO1-E2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

High-density Functional Display of Proteins on Bacteriophage Lambda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Genetically modified filamentous phage as bactericidal agents: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Reporter bacteriophage A511::celB transduces a hyperthermostable glycosidase from Pyrococcus furiosus for rapid and simple detection of viable Listeria cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Therapy of experimental pseudomonas infections with a nonreplicating genetically modified phage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Application of bacteriophages for detection and control of foodborne pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Bacteriophage for biocontrol of foodborne pathogens: calculations and considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Nanofibrous bio-inorganic hybrid structures formed through self-assembly and oriented mineralization of genetically engineered phage nanofibers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Viruses: incredible nanomachines. New advances with filamentous phages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Development of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Programmable assembly of nanoarchitectures using genetically engineered viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Bacteriophages and nanostructured materials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Bacteriophages for plant disease control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Filamentous phage display in the new millennium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Long-term transgene expression in mouse neural progenitor cells modified with phiC31 integrase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Characterization of the catalytic activity of the gamma-phage lysin, PlyG, specific for Bacillus anthracis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Use of bacteriophages as biocontrol agents to control Salmonella associated with seed sprouts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Reversal of obesity by targeted ablation of adipose tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Origin and evolution of eukaryotic large nucleo-cytoplasmic DNA viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Biocontrol of biomass bulking caused by Haliscomenobacter hydrossis using a newly isolated lytic bacteriophage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Dual-surface-modified bacteriophage MS2 as an ideal scaffold for a viral capsid-based drug delivery system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Use of high-affinity cell wall-binding domains of bacteriophage endolysins for immobilization and separation of bacterial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Microviridae goes temperate: microvirus-related proviruses reside in the genomes of Bacteroidetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Molecular modification of T4 bacteriophage proteins and its potential application - review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Bacteriophage resistance mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Virus-based piezoelectric energy generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Amplified protein detection and identification through DNA-conjugated M13 bacteriophage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Ordering of quantum dots using genetically engineered viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Viruses and their potential in bioimaging and biosensing applications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Protein repertoire of double-stranded DNA bacteriophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Bacteriophage endolysins--current state of research and applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Dispersing biofilms with engineered enzymatic bacteriophage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Structural engineering of a phage lysin that targets Gram-negative pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Bacteriophages as biocontrol agents of food pathogens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Viral assembly of oriented quantum dot nanowires

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Virus-based toolkit for the directed synthesis of magnetic and semiconducting nanowires.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Bacteriophages as twenty-first century antibacterial tools for food and medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Intestinal colonization by enteroaggregative Escherichia coli supports long-term bacteriophage replication in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Molecular characterization of a Clostridium difficile bacteriophage and its cloned biologically active endolysin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Advances of development of phage display systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Genetically engineered nanofiber-like viruses for tissue regenerating materials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Engineering phage materials with desired peptide display: rational design sustained through natural selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Peptide phage display as a tool for drug discovery: targeting membrane receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Selection of phage-displayed llama single-domain antibodies that transmigrate across human blood-brain barrier endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Virus-enabled synthesis and assembly of nanowires for lithium ion battery electrodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Stamped microbattery electrodes based on self-assembled M13 viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Biologically templated photocatalytic nanostructures for sustained light-driven water oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Virus-templated assembly of porphyrins into light-harvesting nanoantennae.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

The elusive object of desire--interactions of bacteriophages and their hosts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Production of hydrogen using nanocrystalline protein-templated catalysts on m13 phage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Lysins to kill - a tale of viral weapons of mass destruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Genetically programmed in vivo packaging of protein cargo and its controlled release from bacteriophage P22.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Phage display: concept, innovations, applications and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Surface functionalization of virus-like particles by direct conjugation using azide-alkyne click chemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

A library of organic landscapes on filamentous phage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Detection of biological threats. A challenge for directed molecular evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Genome sequences and characterization of the related Gordonia phages GTE5 and GRU1 and their use as potential biocontrol agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Cell targeting with hybrid Qβ virus-like particles displaying epidermal growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Targeted gene delivery to mammalian cells by filamentous bacteriophage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Filamentous bacteriophage fd as an antigen delivery system in vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Icosahedral virus particles as polyvalent carbohydrate display platforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

E phage gene transfection associated to chemotherapeutic agents increases apoptosis in lung and colon cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

The 1.2-megabase genome sequence of Mimivirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Phage for rapid detection and control of bacterial pathogens in food

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Phage display of intact domains at high copy number: a system based on SOC, the small outer capsid protein of bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Screening of large molecule diversities by phage display

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

A stable phage lysin (Cpl-1) dimer with increased antipneumococcal activity and decreased plasma clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Viruses in the faecal microbiota of monozygotic twins and their mothers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Going viral: next-generation sequencing applied to phage populations in the human gut.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Identification of homing peptides using the in vivo phage display technology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Engineered T4 viral nanoparticles for cellular imaging and flow cytometry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Pneumococcal LytA autolysin, a potent therapeutic agent in experimental peritonitis-sepsis caused by highly beta-lactam-resistant Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Inactivation of indispensable bacterial proteins by early proteins of bacteriophages: implication in antibacterial drug discovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Functional viral metagenomics and the next generation of molecular tools

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Genome sequence of E. coli O104:H4 leads to rapid development of a targeted antimicrobial agent against this emerging pathogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Twenty-three years of Klebsiella phage typing: a review of phage typing of 12 clusters of nosocomial infections, and a comparison of phage typing with K serotyping

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Material binding peptides for nanotechnology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Accelerated bioorthogonal conjugation: a practical method for the ligation of diverse functional molecules to a polyvalent virus scaffold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Phage display for selection of novel binding peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Bacteriophage based probes for pathogen detection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Bacteriophage-Mediated Dispersal of Campylobacter jejuni Biofilms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Pathogen detection using engineered bacteriophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Site-specific recombination by phiC31 integrase and other large serine recombinases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Display of peptides on the surface of tobacco mosaic virus particles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

The interactions of peptides with the innate immune system studied with use of T7 phage peptide display

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Filamentous bacteriophage as a novel therapeutic tool for Alzheimer's disease treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Development of a new, combined rapid method using phage and PCR for detection and identification of viable Mycobacterium paratuberculosis bacteria within 48 hours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Phage display technology for stem cell delivery and systemic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Site-specific and Spatially Controlled Addressability of a New Viral Nanobuilding Block:Sulfolobus islandicusRod-shaped Virus 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Potato virus X as a novel platform for potential biomedical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Display of peptides and proteins on the surface of bacteriophage lambda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

7 January 2021

Bacteriophage Therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Phage display of random peptide libraries: applications, limits, and potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Probing individual environmental bacteria for viruses by using microfluidic digital PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Silica encapsulated SERS nanoprobe conjugated to the bacteriophage tailspike protein for targeted detection of Salmonella.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Mapping of vascular ZIP codes by phage display

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Reduction of Escherichia coli O157:H7 viability on hard surfaces by treatment with a bacteriophage mixture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Isolation and characterisation of two novel coliphages with high potential to control antibiotic-resistant pathogenic Escherichia coli (EHEC and EPEC)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

HWGMWSY, an unanticipated polystyrene binding peptide from random phage display libraries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Phage display: selecting straws instead of a needle from a haystack.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Cell-specific targeting of nanoparticles by multivalent attachment of small molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Selection of peptides with semiconductor binding specificity for directed nanocrystal assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Luminescence based enzyme-labeled phage (Phazyme) assays for rapid detection of Shiga toxin producing Escherichia coli serogroups.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Synthetic viruses: a new opportunity to understand and prevent viral disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa ; a preliminary report of efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Adeno-associated virus mediated gene transfer into lung cancer cells promoting CD40 ligand-based immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Self-assembly and mineralization of genetically modifiable biological nanofibers driven by β-structure formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Development of anti-tumor blood vessel antibodies by phage display method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Virus electrodes for universal biodetection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Evaluation of a biocontrol preparation consisting of Enterobacter asburiae JX1 and a lytic bacteriophage cocktail to suppress the growth of Salmonella Javiana associated with tomatoes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Current advances in Phi29 pRNA biology and its application in drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Phage display screening against a set of targets to establish peptide-based sugar mimetics and molecular docking to predict binding site.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Polyvalent display of RGD motifs on turnip yellow mosaic virus for enhanced stem cell adhesion and spreading

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Isolation and lytic activity of the Listeria bacteriophage endolysin LysZ5 against Listeria monocytogenes in soya milk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

"Push through one-way valve" mechanism of viral DNA packaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Transmembrane delivery and biological effect of human growth hormone via a phage displayed peptide in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Biotemplating rod-like viruses for the synthesis of copper nanorods and nanowires

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

HSV-mediated gene transfer of C3 transferase inhibits Rho to promote axonal regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

Construction of luciferase reporter bacteriophage A511::luxAB for rapid and sensitive detection of viable Listeria cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.017

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2012.09.017

1 reference

27 August 2017

1 reference